Two days after the U.S. Food & Drug Administration signaled it might quash Amgen Inc.’s attempt to usher in a whole new class of virus-based cancer drugs, an advisory panel […]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental Biologics License Application (sBLA) for Opdivo […]
Washington, DC – WEBWIRE – Tuesday, April 28, 2015 IDSA continues to wage a campaign of denial about chronic Lyme in the face of growing scientific evidence that a very […]
[embedded content] According to the results of a new study, teens were able to purchase potentially dangerous supplements at a variety of health food stores across the US, despite labels […]
VANCOUVER, BC–(Marketwired – April 29, 2015) – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its current lead compound APC […]
Illumina, one of the most important companies in biomedicine, is still barely known to the public. But scientists, diagnostics makers, physicians, and Wall Street look at the company with a […]